143 related articles for article (PubMed ID: 38483616)
21. The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients.
Fantini S; Salsi V; Reggiani L; Maiorana A; Zappavigna V
Oncotarget; 2017 Jan; 8(3):4747-4759. PubMed ID: 27902469
[TBL] [Abstract][Full Text] [Related]
22. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
Chia NY; Deng N; Das K; Huang D; Hu L; Zhu Y; Lim KH; Lee MH; Wu J; Sam XX; Tan GS; Wan WK; Yu W; Gan A; Tan AL; Tay ST; Soo KC; Wong WK; Dominguez LT; Ng HH; Rozen S; Goh LK; Teh BT; Tan P
Gut; 2015 May; 64(5):707-19. PubMed ID: 25053715
[TBL] [Abstract][Full Text] [Related]
23. miR-143 Inhibits Cell Proliferation of Gastric Cancer Cells Through Targeting GATA6.
Guoping M; Ran L; Yanru Q
Oncol Res; 2018 Aug; 26(7):1023-1029. PubMed ID: 29321084
[TBL] [Abstract][Full Text] [Related]
24. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.
Martinelli P; Carrillo-de Santa Pau E; Cox T; Sainz B; Dusetti N; Greenhalf W; Rinaldi L; Costello E; Ghaneh P; Malats N; Büchler M; Pajic M; Biankin AV; Iovanna J; Neoptolemos J; Real FX
Gut; 2017 Sep; 66(9):1665-1676. PubMed ID: 27325420
[TBL] [Abstract][Full Text] [Related]
25. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-10a-5p-mediated downregulation of GATA6 inhibits tumor progression in ovarian cancer.
Gao F; Wu Q; Lu D
Hum Cell; 2024 Jan; 37(1):271-284. PubMed ID: 37768544
[TBL] [Abstract][Full Text] [Related]
28. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.
Lin L; Bass AJ; Lockwood WW; Wang Z; Silvers AL; Thomas DG; Chang AC; Lin J; Orringer MB; Li W; Glover TW; Giordano TJ; Lam WL; Meyerson M; Beer DG
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4251-6. PubMed ID: 22375031
[TBL] [Abstract][Full Text] [Related]
29. Spdef deletion rescues the crypt cell proliferation defect in conditional Gata6 null mouse small intestine.
Aronson BE; Stapleton KA; Vissers LA; Stokhuijzen E; Bruijnzeel H; Krasinski SD
BMC Mol Biol; 2014 Jan; 15():3. PubMed ID: 24472151
[TBL] [Abstract][Full Text] [Related]
30. LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma.
Dong C; Zhao Y; Yang S; Jiao X
J Oral Pathol Med; 2023 Jul; 52(6):493-503. PubMed ID: 36856154
[TBL] [Abstract][Full Text] [Related]
31. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.
Zhai S; Zhao L; Lin T; Wang W
J Cell Biochem; 2019 Apr; 120(4):6651-6660. PubMed ID: 30368888
[TBL] [Abstract][Full Text] [Related]
33. Effects of GATA6-AS/MMP9 on malignant progression of endometrial carcinoma.
Zhao Y; Zou X; Wang G; Liu Y; Zhang C; Lu W; Li Q
J BUON; 2021; 26(5):1789-1795. PubMed ID: 34761584
[TBL] [Abstract][Full Text] [Related]
34. Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers.
Sun Z; Yan B
Clin Genet; 2020 Jan; 97(1):64-72. PubMed ID: 31437305
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
36. miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.
Tian F; Chen J; Zheng S; Li D; Zhao X; Jiang P; Li J; Wang S
BMC Cancer; 2017 Mar; 17(1):175. PubMed ID: 28270130
[TBL] [Abstract][Full Text] [Related]
37. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
Chen Z; Zeng H; Guo Y; Liu P; Pan H; Deng A; Hu J
J Exp Clin Cancer Res; 2010 Nov; 29(1):151. PubMed ID: 21092188
[TBL] [Abstract][Full Text] [Related]
38. Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.
Song SH; Jeon MS; Nam JW; Kang JK; Lee YJ; Kang JY; Kim HP; Han SW; Kang GH; Kim TY
Oncogene; 2018 Feb; 37(8):993-1004. PubMed ID: 29106391
[TBL] [Abstract][Full Text] [Related]
39. GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer.
Liu H; Du F; Sun L; Wu Q; Wu J; Tong M; Wang X; Wang Q; Cao T; Gao X; Cao J; Wu N; Nie Y; Fan D; Lu Y; Zhao X
Cell Death Dis; 2019 Jan; 10(2):35. PubMed ID: 30674866
[TBL] [Abstract][Full Text] [Related]
40. Metabolic pathways underlying GATA6 regulating Trastuzumab resistance in Gastric Cancer cells based on untargeted metabolomics.
Chang J; Wang Q; Bhetuwal A; Liu W
Int J Med Sci; 2020; 17(18):3146-3164. PubMed ID: 33173435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
